A study on the effect of convergence patent on corporate management performance

The next-generation technology innovation has drawn a lot of attention as convergence technology capable of creating a new product and a new service market in synergy with new technologies or other areas. The purpose of this study is to find how a ratio of convergence patents to the patents of pharmaceutical/bio enterprises influence corporate management performance. To achieve that, this study traced the 5-year (from 2011 to 2015) management performances of 160 domestic pharmaceutical/bio enterprises. As a result, it was found that a ratio of convergence patents to their owned patents significantly influenced a sales increase rate and an asset increase rate out of corporate management performance factors, and especially gave more significant influence on small & medium business than large business. Most previous studies recognized convergence as an ideal type, whereas this study empirically analyzed the relation between a ratio of convergence patents to corporate owned patents and recent management performance of each one of the enterprises. In the current circumstance where convergence environment is recognized as an universal phenomenon of technology innovation, this study tries to contribute to helping domestic innovation entities establish their technology innovation strategy.